Medicine and Dentistry
Progression Free Survival
100%
Transplantation
100%
Multiple Myeloma
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Diseases
33%
Retrospective Study
33%
Overall Survival
33%
Disease Exacerbation
33%
Autologous Stem Cell Transplantation
33%
Immunoglobulin Producing Cell
33%
Keyphrases
Remission
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Multiple Myeloma Patients
100%
Long-term Responders
100%
Median Progression-free Survival
22%
Standard of Care
11%
Median Overall Survival
11%
Complete Response
11%
Disease Progression
11%
Progression-free Survival
11%
Durable Response
11%
Stage I Disease
11%
Leading Causes of Death
11%
Bone Marrow Plasma Cells
11%
Newly Diagnosed multiple Myeloma
11%
Post-transplant Management
11%
High-risk Cytogenetics
11%
Riss
11%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Remission
100%
Progression Free Survival
100%
Diseases
33%
Retrospective Study
33%
Overall Survival
33%
Disease Exacerbation
33%
Immunology and Microbiology
Multiple Myeloma
100%
Progression Free Survival
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Overall Survival
33%
Immunoglobulin Producing Cell
33%
Autologous Stem Cell Transplantation
33%
Biochemistry, Genetics and Molecular Biology
Progression Free Survival
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Cytogenetics
33%
Overall Survival
33%
Immunoglobulin Producing Cell
33%
Retrospective Study
33%
Autologous Stem Cell Transplantation
33%